SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-02-001166
Filing Date
2002-03-29
Accepted
2002-03-29 00:00:00
Documents
5
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 10-K j3024_10k.htm 10-K 1230462
3 EX-10.29 j3024_ex10d29.htm EX-10.29 45678
4 EX-10.30 j3024_ex10d30.htm EX-10.30 45611
5 EX-21.1 j3024_ex21d1.htm EX-21.1 3892
6 EX-23.1 j3024_ex23d1.htm EX-23.1 3857
  Complete submission text file 0001104659-02-001166.txt   1331294
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21481 | Film No.: 02594450
SIC: 2836 Biological Products, (No Diagnostic Substances)